投稿问答最小化  关闭

万维书刊APP下载
您的位置:万维书刊网 >> 期刊动态

EUROINTERVENTION《欧洲介入杂志》投稿须知(官网信息)

2021/5/27 11:27:30 来源:官网信息 阅读:1347 发布者:
编者按:以下信息,由万维书刊网根据期刊官网信息整理发布!仅供投稿参考!

Author Centre

General Information

Welcome

Welcome to the Author’s Centre and thank you for considering EuroIntervention (EIJ) as the home for your manuscript. In this section you will find basic information, resources and guidelines to steer you through the manuscript submission, review and publication process. Learn about:

Our Editorial Process

How to prepare your manuscript for Submission

What to expect After Acceptance

If you have any question, Contact Us with your request or submit a Pre-submission Enquiry.

About EIJ

EIJ publishes peer-reviewed articles in English over the entire spectrum of diagnostics and interventions in cardiovascular medicine. In addition to clinical and translational research studies, EIJ publishes state-of-the-art reviews, meta-analyses, expert consensus documents, trial design papers, short reports, editorials and viewpoints. Case reports are not considered for publication except when they include striking images of significant educational value in the form of “Interventional flashlights”. EIJ is the official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Why EIJ?

Since its inception in 2005, the mission of EIJ has been to bring healthcare providers research studies that foster innovation in interventional cardiology and add value to clinical practice. With a 2019 impact factor of 3,993, access to state-of-the-art media at PCRonline and the journal’s own website, EIJ is at the cutting edge of scientific publications in interventional cardiology today.

Manuscripts submitted to EIJ benefit from:

A high-standard, peer-review service that is typically completed from submission to decision in 4 weeks for manuscripts that are sent out for external peer review.

Rapid editorial decisions for manuscripts that do not pass the initial screening phase and are typically returned to the authors in 1 to 3 business days from submission without external peer review.

Manuscripts accepted by EIJ benefit from:

Early Access online publication with DOI assignment in the form of Just Accepted Article (JAA).

Prompt indexing in MEDLINE®/PubMed®, Science Citation Index® (ISI), SciVerse, Scopus.

Worldwide reach and visibility through the media channels of EIJ, including PCRonline (website and newsletters), Facebook and Twitter. EIJ ranks 1st among interventional cardiology journals in terms of scholarly impact based on Altmetric Score.

Impact on the interventional community with Editorial Office assistance to coordinate the timing of online publication with presentation at medical conferences.

Tracking of article performance through a dedicated metrics box on the article page.

Pre-submission options

EIJ article types may be unsolicited (submitted at author discretion via Editorial Manager) or solicited (invited by the editors).

Pre-submission enquiries - Authors who are uncertain of the suitability of their manuscript for submission may consider sending a pre-submission enquiry to save substantial time and effort. The editorial staff will endeavour to respond to pre-submission enquiries by e-mail in 3 business days. Pre-submission enquiries should include a 250-word summary or synopsis of the proposal and the intended list of authors.

Fast track review - Exceptionally EIJ will consider petitions for fast track review. In this case, authors should submit their manuscript via editorial manager, ensuring that the manuscript adheres to EuroIntervention’s authors instructions. An accompanying cover letter should detail why the authors deem the manuscript suitable for fast track review. The Editors will decide and communicate within 2 business days whether the manuscript is suitable for fast track or regular review. Approval for fast track review does not guarantee acceptance of the manuscript, nor does it guarantee expedited publication should the manuscript is accepted.

Simultaneous publication - EIJ considers fast-track review and simultaneous publication of trials and science scheduled for presentation in leading international conferences. Manuscripts can be considered if submitted at least 50 days before the scheduled presentation. A response on the suitability of the manuscript for this option is normally communicated within 2 business days. Authors who are interested in this service should submit a pre-submission enquiry via https://eurointervention.pcronline.com. If finally accepted for publication, the manuscript will be online as Just Accepted Article (JAA) coinciding with the presentation and in accordance with the policy of the conference.

Publication Embargo

A publication embargo may be requested if the authors are presenting their abstracts/results at a subsequent conference. The publication of these submissions can be delayed or fast tracked accordingly. Should authors wish for their submissions to be published with an embargo, authors should include a note in the cover letter at the time of submission. The exact date and time of the presentation should be mentioned.

Please note that this remains at the discretion of the editorial board and is pending acceptance.

Invited or commissioned articles - State-of-the-art reviews, editorials and viewpoints are usually solicited by the editors prior to submission. Authors who are interested in proposing ideas for these types of articles may also send pre-submission enquiries via https://eurointervention.pcronline.com accompanied by a 250-word summary or synopsis of their proposal and the intended list of authors.

Article Categories

When sending either a new manuscript or a pre-submission enquiry to EIJ, authors must identify the category type of their submission as described below.

All word count limits are intended for the text from the introduction to the conclusion (excluding Short Reports), and they exclude abstract, figure legends, and table notes. For any text exceeding the words limit, upload of supplementary material is permitted. For some categories, a Central Illustration and/or a panel named “Impact on daily practice” is required.

EuroIntervention publishes:

Clinical Research

Translational Research

Meta-Analysis

Expert Consensus

State-of-the-Art Review

Trial Design

Short Report

Editorial

Viewpoint

Interventional Flashlight

Letter to the Editor and Replies

Frequently Asked Questions

After Acceptance

Clinical Research: This type of article includes original randomised or large observational studies (preferably case-controlled) based on cohorts of subjects or patients. The Editors will assign higher priority to articles of high methodological quality that address original questions with direct practical implications. This includes subgroup analyses from large-scale randomised clinical trials if they are pre-specified. Conversely, they will assign lower priority to observational studies that are not case-controlled and to post hoc subgroup analyses from prior studies that lack novelty and do not convey significant additional information. Case studies and reports are not acceptable in this category. EIJ advises authors to follow the guidelines for their study type available on the website Equator Network. All clinical trials should follow the CONSORT guidelines and such papers must be accompanied by a CONSORT table indicating compliance with these reporting standards and a statement on ethical approval. All trials should be registered prospectively in www.clinicaltrials.gov and such papers should include the registration number. Reporting of observational studies should follow the STROBE guidelines.

Translational Research: This type of article includes high-quality experimental studies (e.g., bench testing or conducted in animals, ex vivo or in vivo) with results that have direct clinical translation or implication for future research. All animal studies should follow the ARRIVE guidelines.

Meta-Analysis: This type of article includes meta-analyses of randomised clinical trials (with observational data included only if statistically adjusted) that adhere to international standards. The Editors will assign higher priority to timely individual patient data meta-analyses and meta-analyses that address meaningful and original clinical questions, summarise high-quality data and apply a number of appropriate sensitivity analyses to explore sources of heterogeneity. Submission of duplicate or overlapping meta-analyses is discouraged and, when previous meta-analyses on the topic exist, differences and improvements need to be listed in the cover letter and in the text. Submission of meta-analyses based on small-scale studies and/or low-quality data is discouraged. Submission of the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) checklist (http://www.prisma-statement.org) is required as supplementary material. Registration in the PROSPERO database is encouraged and represents a criterion of priority. Extensions of PRISMA recommendations for network (PRISMA-NMA) and individual patient data meta-analyses (PRISMA-IPD) must be followed when these types of meta-analysis are conducted. Guidelines for Meta-Analyses and Systematic Reviews of Observational Studies (MOOSE) must be followed in meta-analyses of observational studies.

Expert Consensus: This type of article includes guidance documents or position statements representing the output of established international organisations on topics of broad contemporary interest. The Editors will assign higher priority to timely documents that inform clinical practice and represent the consensus of multiple international scientific societies. Pre-submission enquiry is strongly recommended before submission.

State-of-the-Art-Review: This type of article includes evidence-based, authoritative reviews on interventional topics, intended for a general audience. This kind of submission must address the clinical problem, the evidence, the areas of uncertainty, the relevant guidelines from professional societies and provide expert conclusions and recommendations for practice. The Editors will assign higher priority to articles of relevant and contemporary interest, with high-quality display materials. These articles are usually by invitation, but proposals are admitted in the form of pre-submission enquiries. The proposal will be discussed by the Editors and, if it is considered acceptable, a formal invitation will follow. All state-of-the-art papers are subject to external peer review.

Trial Design: This type of article includes study designs complementing the publication of large-scale randomised trials registered in clinicaltrials.gov or similar online databases. Study protocols of small-scale and/or translational or pilot studies are not acceptable in this category.

Trial design: This category type must be submitted along with the correct CONSORT table.

Short Report: This type of article includes original investigation fulfilling the criteria for an original clinical or translational research paper but in a condensed format. It may occur that authors of full length original clinical or translational research papers are asked to reshape their article in the form of a short report.

Editorial: This type of article includes solicited commentaries of articles published in the Journal. The Editors encourage a critical appraisal of the commented articles and perspectives on directions for the field. Invited authors will receive specific instructions and timelines.

Viewpoint: This type of article includes authoritative perspectives on interventional topics in a brief, accessible style. The Editors will assign higher priority to articles of relevant and contemporary interest. These articles are usually by invitation, but proposals are admitted in the form of pre-submission enquiries. The proposal will be discussed by the Editors and, if it is considered acceptable, a formal invitation will follow. All viewpoints are subject to external peer review.

Interventional Flashlight: The goal of this type of article is to present a memorable finding in interventional cardiology, together with an exceptional, high-quality image and description. Although often presented within the context of a case, the image is not intended to be a vehicle for case reports. The Editors will evaluate this striking and illustrative clinical image before the review process. They will decide if the manuscript should be published as an Interventional flashlight or will propose publication on the PCRonline website. Only submissions accepted as Interventional flashlights will be published in EIJ, allocated a DOI and be submitted for PubMed listing. Submissions selected to be on the PCRonline website will not be allocated a DOI and will not be indexed on PubMed. If the authors exceed the word count, the Editors will not consider the manuscript for peer review and the manuscript will be returned unread. Authors are encouraged to submit additional moving images, which will appear online.

Letter to the Editor and Replies: This type of article includes a comment on a specific manuscript that has appeared in EIJ (>4 weeks). If the letter is accepted for publication, a reply from the authors of the original paper will be sought and the letter will be published along with the reply.

……

更多详情:

https://eurointervention.pcronline.com/author-centre/welcome


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com